What are cytomaxes (natural peptides)?
Cytomaxes are natural peptide bioregulators derived from animal organs and tissues. They were developed by Professor Vladimir Khavinson's team and are the first generation of peptide bioregulators with the longest history of clinical research.
The cytomaxes production process involves special processing of organ tissues, during which short peptides (2-4 amino acid chains) are extracted. These peptides retain their full natural informational structure specific to a particular organ.
Most popular cytomaxes:
- Cerluten - brain and central nervous system peptides
- Chelohart - heart muscle (myocardial) peptides
- Ventfort - blood vessel wall peptides
- Vladonix - thymus peptides
- Sigumir - cartilage and bone tissue peptides
- Bonomarlot - bone marrow peptides
- Bonothyrk - thyroid peptides




Advantages of cytomaxes:
- Complete peptide complex with full natural information
- Longest clinical research history (40+ years)
- Stronger and broader effect on the organ
- Ideal for intensive restorative courses
Synthetic peptides (cytogens) are created in the laboratory
What are cytogens (synthetic peptides)?
Cytogens are synthetic peptide bioregulators created in the laboratory by reproducing the structure of natural peptides. They are next-generation products developed based on the results of cytomaxes research.
Each cytogen is a single specific peptide sequence that precisely matches the most effective fragment of a natural peptide. They are manufactured by chemical synthesis and therefore are not of animal origin.
Most popular cytogens:
- Pinealon - synthetic brain and nervous system peptide
- Vesugen - synthetic vascular peptide
- Kristagen - synthetic immune system peptide



Advantages of cytogens:
- Precisely defined molecular structure
- Suitable for vegetarians and vegans (non-animal origin)
- Easier to standardize the production process
- Ideal for maintenance use between cytomaxes courses
Comparison table
| Property | Cytomaxes | Cytogens |
|---|---|---|
| Origin | Natural (animal tissues) | Synthetic (laboratory) |
| Composition | Peptide complex | Single peptide |
| Effect strength | Stronger, broader | Targeted, narrower |
| Suitable for vegetarians | No | Yes |
| Recommended use | Main courses | Maintenance courses |
When to choose cytomaxes?
Cytomaxes are the best choice when:
- You are starting your first peptide course and want maximum effect
- You have specific health problems you want to address
- You want to perform an intensive restorative course
- You are looking for a broader effect on a specific organ
When to choose cytogens?
Cytogens are a better fit when:
- You have already completed a cytomaxes course and want to maintain results
- You follow a vegetarian or vegan diet
- You want a targeted effect on a specific function
- You are taking peptides for preventive purposes


Optimal combination: cytomaxes + cytogens
Many specialists recommend combining both types for optimal results. A popular scheme:
- Main course (30 days): cytomaxes - e.g., Chelohart for the heart
- Maintenance course (30 days, after a 1-2 month break): cytogens - e.g., Vesugen for blood vessels
- Repeat the cycle every 4-6 months
It is also possible to take cytomaxes and cytogens simultaneously for different organs. For example, Cerluten (cytomaxes for the brain) together with Kristagen (cytogen for immunity).
Regardless of which type you choose, peptide bioregulators are a safe and scientifically proven way to maintain organ health and slow down the aging process. Visit our store and explore the full range.
Clinical studies of peptide bioregulators
Sources
- Khavinson, V.Kh. "Peptides and Ageing." Neuroendocrinology Letters, Vol. 24, No. 3-4, 2003, pp. 144-149.
- Khavinson, V.Kh., Malinin, V.V. Gerontological Aspects of Genome Peptide Regulation. Karger, Basel, 2005.
- Khavinson, V. "Peptide regulation of aging: 35-year research experience." Bulletin of Experimental Biology and Medicine, Vol. 152, No. 1, 2011, pp. 7-12.
- Institute of Bioregulation and Gerontology, Saint Petersburg - scientific publications and clinical trial data.
- Khavinson, V.Kh., et al. "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells." Bulletin of Experimental Biology and Medicine, Vol. 135, No. 6, 2003, pp. 590-592.